Delivery Order SPE2DR25D3001-SPE2DR26F3F5A
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,139.18 for Shingrix vial kits on May 14, 2025, with an ultimate completion date of May 15, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $4,962.90 to AmerisourceBergen Drug Corp for Shingrix vial kits on November 5, 2025, with completion expected by November 6, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) and is a...
- The Defense Logistics Agency awarded a $15,032.22 delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is listed as Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,139.18 to AmerisourceBergen Drug Corp for Shingrix vial kits on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for Shingrix vial kits, valued at $1,139.18, with an ultimate completion date of June 26, 2025. This is a firm fixed-price delivery order issued without a set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes...
- The Defense Logistics Agency awarded a $14,012.49 delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of August 18, 2025. This contract represents a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) in...
- The Defense Logistics Agency awarded a delivery order valued at $10,533.22 to AmerisourceBergen Drug Corp for Shingrix vial kits on September 11, 2025, with completion scheduled for September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for prevention of herpes zoster (shingles) and post-herpetic neuralgia in...
- The Defense Logistics Agency awarded a delivery order valued at $3,417.54 to AmerisourceBergen Drug Corp for Shingrix vial kits, a vaccine product for the prevention of herpes zoster (shingles) in adults. The contract was awarded on September 4, 2025, with an ultimate completion date of September 5, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be completed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits valued at $8,769.12, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $11,391.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with a completion date of June 6, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion vehicle designated SPE2DX and running through December 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in...
- SPE2DR25D3001Indefinite Delivery Contract
- SPE2DR25D3001-SPE2DR26F3F5ADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Shingrix vial kits, a recombinant zoster vaccine used for prevention of herpes zoster in older adults. This firm fixed-price delivery order, valued at $4,726.12, is classified as a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through December 2026. The contract requires delivery to AmerisourceBergen's location in Conshohocken, Pennsylvania, with completion expected by November 18, 2025. No set-aside designation was utilized for this competitively awarded delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency and military healthcare systems. The company's DLA Troop Support Medical IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of an extensive range of pharmaceutical products, vaccines, and medical supplies to support military healthcare programs worldwide. This delivery order for Shingrix vial kits represents one of numerous routine pharmaceutical deliveries under this prime contract vehicle, demonstrating AmerisourceBergen's ongoing role in fulfilling federal vaccine and immunization needs across the defense healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 11/17/25 |